Read More 1 minute read Analyst Ratings Downgrades News Societe Generale Downgrades Alcon to Sell By Benzinga Newsdesk November 17, 2:34 PM Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Hold to Sell. ALC
Read More 15 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For November 17, 2022 By Benzinga Insights November 17, 11:13 AM Upgrades AAP
Read More 1 minute read Analyst Ratings Downgrades News Monness, Crespi, Hardt Downgrades Salesforce to Neutral By Benzinga Newsdesk November 17, 10:12 AM Monness, Crespi, Hardt analyst Brian White downgrades Salesforce (NYSE:CRM) from Buy to Neutral. CRM
Read More 1 minute read Analyst Ratings Downgrades News Wolfe Research Downgrades Saia to Peer Perform By Benzinga Newsdesk November 17, 10:08 AM Wolfe Research analyst Scott Group downgrades Saia (NASDAQ:SAIA) from Outperform to Peer Perform. SAIA
Read More 1 minute read Analyst Ratings Downgrades News Price Target UBS Downgrades NIO to Neutral, Lowers Price Target to $13 By Benzinga Newsdesk November 17, 10:05 AM UBS analyst Paul Gong downgrades NIO (NYSE:NIO) from Buy to Neutral and lowers the price target from $32 to $13. NIO
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades Science Applications Intl to Hold, Announces $110 Price Target By Benzinga Newsdesk November 17, 8:21 AM Jefferies analyst Sheila Kahyaoglu downgrades Science Applications Intl (NYSE:SAIC) from Buy to Hold and announces $110 price target. SAIC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Quest Diagnostics to Sell, Lowers Price Target to $125 By Benzinga Newsdesk November 17, 7:23 AM Citigroup analyst Patrick Donnelly downgrades Quest Diagnostics (NYSE:DGX) from Neutral to Sell and lowers the price target from $145 to $125. DGX
Read More 1 minute read Analyst Ratings Downgrades News Price Target BMO Capital Downgrades Target to Market Perform, Lowers Price Target to $165 By Benzinga Newsdesk November 17, 6:46 AM BMO Capital analyst Kelly Bania downgrades Target (NYSE:TGT) from Outperform to Market Perform and lowers the price target from $190 to $165. TGT
Read More 1 minute read Analyst Ratings Downgrades News Price Target B of A Securities Downgrades Surrozen to Underperform, Lowers Price Target to $1 By Benzinga Newsdesk November 17, 6:40 AM B of A Securities analyst Tazeen Ahmad downgrades Surrozen (NASDAQ:SRZN) from Neutral to Underperform and lowers the price target from $5 to $1. SRZN
Read More 1 minute read Analyst Ratings Downgrades News BTIG Downgrades REE Automotive to Neutral By Benzinga Newsdesk November 17, 6:37 AM BTIG analyst Gregory Lewis downgrades REE Automotive (NASDAQ:REE) from Buy to Neutral. REE